Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1007518-24-2

3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1007518-24-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1007518-24-2 Structure

  • Basic information

    1. Product Name: 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE)
    2. Synonyms: 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE);3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA
    3. CAS NO:1007518-24-2
    4. Molecular Formula: C6H6BrN3
    5. Molecular Weight: 200.03594
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1007518-24-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE)(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE)(1007518-24-2)
    11. EPA Substance Registry System: 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile(SALTDATA: FREE)(1007518-24-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1007518-24-2(Hazardous Substances Data)

1007518-24-2 Usage

Chemical structure

Nitrile derivative with a pyrazole ring and a bromine substituent

Uses

Organic synthesis, pharmaceutical research, building block for the synthesis of various heterocyclic compounds and pharmaceutical intermediates

Safety

Should be handled with care to avoid risks to human health and the environment if not properly managed

Check Digit Verification of cas no

The CAS Registry Mumber 1007518-24-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,5,1 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1007518-24:
(9*1)+(8*0)+(7*0)+(6*7)+(5*5)+(4*1)+(3*8)+(2*2)+(1*4)=112
112 % 10 = 2
So 1007518-24-2 is a valid CAS Registry Number.

1007518-24-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-bromopyrazol-1-yl)propanenitrile

1.2 Other means of identification

Product number -
Other names 3-(4-bromo-1H-pyrazol-1-yl)propanenitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1007518-24-2 SDS

1007518-24-2Relevant articles and documents

NURR1 RECEPTOR MODULATORS

-

Paragraph 0646; 0765-0767, (2020/09/08)

Described herein, inter alia, are Nurr1 receptor modulators and uses thereof. In an aspect is provided a method for treating a disease associated with dysregulation and/or degeneration of dopaminergic neurons in the central nervous system of a subject in need thereof, the method including administering to the subject in need thereof a therapeutically effective amount of a compound described herein.

HETEROARYL COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF

-

Paragraph 00499, (2016/01/25)

The present invention provides herein is a heteroaryl compound or a stereoisomer, a geometric isomer, a tautomer, a racemate, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, as well as a pharmaceutical composition containing the compound disclosed herein. The present invention also provides herein is use of the compound or the pharmaceutical composition thereof disclosed herein in the manufacture of a medicine for treating autoimmune diseases or proliferative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1007518-24-2